Toxic shock syndrome secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
{{CMG}};{{AE}}{{MIR}}
{{CMG}};{{AE}}{{MIR}}
{{Toxic shock syndrome}}
{{Toxic shock syndrome}}
Line 5: Line 6:


== Secondary Prevention ==
== Secondary Prevention ==
Several [[antibiotic]] regimens have been successful in eradicating group A [[streptococcus]] from the [[pharynx]] of chronic carriers (i.e., [[rifampin]] plus intramuscular [[Benzathine penicillin G|benzathine penicillin]] or a 10-day course of a second-generation [[cephalosporin]] or [[clindamycin]]). However, there are limited data concerning [[chemoprophylaxis]] for severe invasive group A [[Streptococcus|streptococcal]] or staphylococcal infections.<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review &#124; AMERICAN ACADEMY OF PEDIATRICS &#124; Pediatrics |format= |work= |accessdate=}}</ref><ref name="pmid19980033">{{cite journal |vauthors=Wylie A |title=Epithelioma of Soft Palate and Uvula |journal=Proc. R. Soc. Med. |volume=11 |issue=Laryngol Sect |pages=110–1 |year=1918 |pmid=19980033 |pmc=2066844 |doi= |url=}}</ref>
One of the major complications of [[toxic shock syndrome]] is that it increase the risk of disease re-currence. This condition can be controlled by [[chemoprophylaxis]] of patients with a past medical history of [[Toxic shock syndrome|TSS]]. However, there is limited data concerning [[chemoprophylaxis]] for severe invasive group A [[Streptococcus|streptococcal]] or staphylococcal infections.<ref name="urlSevere Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics">{{cite web |url=http://pediatrics.aappublications.org/content/101/1/136.short |title=Severe Invasive Group A Streptococcal Infections: A Subject Review &#124; AMERICAN ACADEMY OF PEDIATRICS &#124; Pediatrics |format= |work= |accessdate=}}</ref><ref name="pmid19980033">{{cite journal |vauthors=Wylie A |title=Epithelioma of Soft Palate and Uvula |journal=Proc. R. Soc. Med. |volume=11 |issue=Laryngol Sect |pages=110–1 |year=1918 |pmid=19980033 |pmc=2066844 |doi= |url=}}</ref>


__NOTOC__
*Also researchers advice not to continue tampon usage after a TSS, to prevent the recurrence of the disease.
 
*Several [[antibiotic]] regimens have been successful in eradicating group A [[streptococcus]] from the [[pharynx]] of chronic carriers i.e.,
**[[Rifampin]] plus intramuscular [[Benzathine penicillin G|benzathine penicillin]] or
**A 10-day course of a second-generation [[cephalosporin]] or
**[[Clindamycin]])


==References==
==References==
Line 14: Line 20:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Syndromes]]
[[Category:Syndromes]]
[[Category:Needs content]]
[[Category:Emergency mdicine]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Needs content]]

Latest revision as of 00:27, 30 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]

Toxic shock syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic Shock Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic shock syndrome secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic shock syndrome secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic shock syndrome secondary prevention

CDC on Toxic shock syndrome secondary prevention

Toxic shock syndrome secondary prevention in the news

Blogs on Toxic shock syndrome secondary prevention

Directions to Hospitals Treating Toxic shock syndrome

Risk calculators and risk factors for Toxic shock syndrome secondary prevention

Overview:

Secondary prevention strategies following toxic shock syndrome (TSS) include chemoprophylaxis for invasive group A streptococcus or staphylococcus carriers. Although it is still not certain to be helpful.

Secondary Prevention

One of the major complications of toxic shock syndrome is that it increase the risk of disease re-currence. This condition can be controlled by chemoprophylaxis of patients with a past medical history of TSS. However, there is limited data concerning chemoprophylaxis for severe invasive group A streptococcal or staphylococcal infections.[1][2]

  • Also researchers advice not to continue tampon usage after a TSS, to prevent the recurrence of the disease.

References

  1. "Severe Invasive Group A Streptococcal Infections: A Subject Review | AMERICAN ACADEMY OF PEDIATRICS | Pediatrics".
  2. Wylie A (1918). "Epithelioma of Soft Palate and Uvula". Proc. R. Soc. Med. 11 (Laryngol Sect): 110–1. PMC 2066844. PMID 19980033.